ImmunoGenesis

Industry · 8 registered clinical trials — 2 currently recruiting.

Status	Trial	Phase	Started
Recruiting	A Study of Evofosfamide in Combination with Zalifrelimab and Balstilimab Metastatic Prostate Cancer, Metastatic Head and Neck Squamous Cell Carcinoma, Metastatic Pancreatic Cancer	Phase 1 / Phase 2	2025-01-08
Recruiting	Study to Evaluate IMGS-001 Treatment in Patients With Relapsed or Refractory Advanced Solid Tumors Solid Tumor	Phase 1	2023-09-07
Terminated	Study of TH-302 or Placebo in Combination With Pemetrexed in Patients With Non-squamous Non-small Cell Lung Ca Non-small Cell Lung Cancer	Phase 2	2014-06-01
Terminated	Phase I TH-302 Plus Gemcitabine Plus Nab-Paclitaxel in Pancreatic Cancer Pancreatic Cancer	Phase 1	2014-01-01
Terminated	A Phase 2 Biomarker - Enriched Study of TH-302 in Subjects With Advanced Melanoma Metastatic Melanoma	Phase 2	2013-05-01
Completed	Clinical Trial Testing TH-302 in Combination With Gemcitabine in Previously Untreated Subjects With Metastatic Metastatic or Locally Advanced Unresectable Pancreatic Adenocarcinoma	Phase 3	2012-12-01
Completed	Study of the Safety and Efficacy of TH-302 in Combination With Gemcitabine Compared With Gemcitabine Alone in Pancreatic Adenocarcinoma	Phase 2	2010-06-01
Completed	Dose-Escalation Study of TH-302 in Combination With Doxorubicin to Treat Patients With Advanced Soft Tissue Sa Soft Tissue Sarcoma	Phase 1 / Phase 2	2008-08-01